Patents by Inventor Santiago Ramon-Garcia

Santiago Ramon-Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sanfetrinem or a salt or ester thereof for use in treating mycobacterial infection
    Patent number: 11253500
    Abstract: The present invention relates to or a pharmaceutically acceptable salt or ester prodrug thereof for use in the treatment of a mycobacterial infection or disease resulting from a mycobacterial infection, such as tuberculosis.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: February 22, 2022
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: David Barros Aguirre, Robert H. Bates, Ruben Gonzalez Del Rio, Alfonso Mendoza Losana, Santiago Ramón García
  • SANFETRINEM OR A SALT OR ESTER THEREOF FOR USE IN TREATING MYCOBACTERIAL INFECTION
    Publication number: 20200289462
    Abstract: The present invention relates to or a pharmaceutically acceptable salt or ester prodrug thereof for use in the treatment of a mycobacterial infection or disease resulting from a mycobacterial infection, such as tuberculosis.
    Type: Application
    Filed: May 4, 2018
    Publication date: September 17, 2020
    Inventors: David BARROS AGUIRRE, Robert H. BATES, Ruben GONZALEZ DEL RIO, Alfonso MENDOZA LOSANA, Santiago RAMÓN GARCÍA
  • Avermectins and milbemycins as anti-mycobacterial agents
    Patent number: 9308215
    Abstract: The present invention relates to methods of treating a mycobacterial infection. In particular, this invention relates to methods, uses and compounds for use in treating mycobacterial infections, including tuberculosis. For example, the compounds may be an avermectin or a milbemycin. The avermectin or milbemycin may be selected from, but not limited to, one or more of ivermectin, moxidectin or selamectin. Exemplary microbial infections that may be treated include, but are not limited to, infections caused by Mycobacterium tuberculosis, Mycobacterium bovis, other mycobacteria of the tuberculosis complex, and non-tuberculous mycobacteria, including Mycobacterium ulcerans.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: April 12, 2016
    Inventors: Charles J. Thompson, Santiago Ramon-Garcia, Leah Elizabeth Lim
  • Avermectins and Milbemycins as Anti-Mycobacterial Agents
    Publication number: 20140315842
    Abstract: The present invention relates to methods of treating a mycobacterial infection. In particular, this invention relates to methods, uses and compounds for use in treating mycobacterial infections, including tuberculosis. For example, the compounds may be an avermectin or a milbemycin. The avermectin or milbemycin may be selected from, but not limited to, one or more of ivermectin, moxidectin or selamectin. Exemplary microbial infections that may be treated include, but are not limited to, infections caused by Mycobacterium tuberculosis, Mycobacterium bovis, other mycobacteria of the tuberculosis complex, and non-tuberculous mycobacteria, including Mycobacterium ulcerans.
    Type: Application
    Filed: April 16, 2014
    Publication date: October 23, 2014
    Inventors: Charles J. Thompson, Santiago Ramon-Garcia, Leah Elizabeth Lim